Management of Hyperuricemia and Gout in CKD

被引：27

作者：

Gaffo, Angelo L. ^{[1
]}

Saag, Kenneth G. ^{[2
]}

机构：

[1] Birmingham VA Med Ctr, Birmingham, AL USA

[2] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA

来源：

AMERICAN JOURNAL OF KIDNEY DISEASES | 2008年 / 52卷 / 05期

关键词：

Management; hyperuricemia; gout; chronic kidney disease;

D O I：

10.1053/j.ajkd.2008.07.035

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：994 / 1009

页数：16

共 137 条

[1] New-onset gout after kidney transplantation: Incidence, risk factors and implications [J].

Abbott, KC ;

Kimmel, PL ;

Dharnidharka, V ;

Oglesby, RJ ;

Agodoa, LY ;

Caillard, S .

TRANSPLANTATION, 2005, 80 (10) :1383-1391

[2] DOES COLCHICINE WORK - THE RESULTS OF THE 1ST CONTROLLED-STUDY IN ACUTE GOUT [J].

AHERN, MJ ;

REID, C ;

GORDON, TP ;

MCCREDIE, M ;

BROOKS, PM ;

JONES, M .

AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1987, 17 (03) :301-304

[3]

ALTMAN RD, 1988, J RHEUMATOL, V15, P1422

[4] Safety of colchicine in dialysis patients [J].

Anderson-Hoog, T ;

Patel, B .

SEMINARS IN DIALYSIS, 2003, 16 (05) :412-413

[5] Uric acid and survival in chronic heart failure - Validation and application in metabolic, functional, and Hemodynamic staging [J].

Anker, SD ;

Doehner, W ;

Rauchhaus, M ;

Sharma, R ;

Francis, D ;

Knosalla, C ;

Davos, CH ;

Cicoira, M ;

Shamim, W ;

Kemp, M ;

Segal, R ;

Osterziel, KJ ;

Leyva, F ;

Hetzer, R ;

Ponikowski, P ;

Coats, AJS .

CIRCULATION, 2003, 107 (15) :1991-1997

[6]

Arromdee E, 2002, J RHEUMATOL, V29, P2403

[7] COMPARISON OF PARENTERAL ADRENOCORTICOTROPIC HORMONE WITH ORAL INDOMETHACIN IN THE TREATMENT OF ACUTE GOUT [J].

AXELROD, D ;

PRESTON, S .

ARTHRITIS AND RHEUMATISM, 1988, 31 (06) :803-805

[8] REQUIEM FOR GOUTY NEPHROPATHY [J].

BECK, LH ;

HARRINGTON, JT ;

KASSIRER, JP ;

PERRONE, R ;

MADIAS, NE ;

STROM, J ;

KURTIN, P ;

CANZANELLO, V .

KIDNEY INTERNATIONAL, 1986, 30 (02) :280-287

[9] Febuxostat (TMX-67), a novel, non-purine, selective inhibitor of xanthine oxidase, is safe and decreases serum urate in healthy volunteers [J].

Becker, MA ;

Kisicki, J ;

Khosravan, R ;

Wu, J ;

Mulford, D ;

Hunt, B ;

MacDonald, P ;

Joseph-Ridge, N .

NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2004, 23 (8-9) :1111-1116

[10] Febuxostat compared with allopurinol in patients with hyperuricemia and gout [J].

Becker, MA ;

Schumacher, HR ;

Wortmann, RL ;

MacDonald, PA ;

Eustace, D ;

Palo, WA ;

Streit, J ;

Joseph-Ridge, N .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (23) :2450-2461

← 1 2 3 4 5 6 7 8 9 10 →